European Journal of Surgical Oncology’s Post

NOSES technique shows advantages over conventional surgeries for colorectal cancer 🪡 read our summary 👉 https://lnkd.in/gUhXdrqK by Malev S, Zhang H (...) Wang X et 5 al. in Front Surg

Retroperitoneal lymph node dissection (RPLND) for testicular cancer can be a challenging surgery, even for the most experienced urologic oncologists. In part one of this special two-part series, host Dr. Aditya Bagrodia invites Society of Urologic Oncologists (SUO) members Dr. Timothy Masterson (Indiana University) and Dr. Robert Hamilton (Princess Margaret Hospital/University of Toronto) to cover current approaches to post-chemotherapy RPLND. First, the urologists delve into the technical considerations and perioperative planning for post-chemotherapy retroperitoneal lymph node dissections (RPLND) in patients with germ cell tumors. They discuss the importance of patient preparation, imaging assessments, and surgical approaches. Additionally, they explain their own surgical techniques as well as tips for dealing with operative complications. To end, their discussion addresses the importance of a multidisciplinary team and practical tips for ensuring successful surgical outcomes. https://lnkd.in/g3Qsutrx #URO201 Society of Urologic Oncology, Inc

The study included 1,600 women with early breast cancer who were planned to be treated with surgery. Half of these patients, constituting the control group, received standard surgery followed by standard post-operative treatment including chemotherapy, hormone therapy and radiotherapy as per guidelines. The other half, constituting the intervention group, received an injection of a commonly used local anaesthesia agent, 0.5% lidocaine, all around the tumor, just prior to surgery. They then underwent standard surgery followed by the same postoperative treatment as was given in the control group. The results of this study show that this simple, low-cost intervention significantly and substantially increases the cure rates and survival of breast cancer patients, with a benefit that is ongoing for several years after surgery. The injection requires no additional expertise, is inexpensive, and can result in saving up to 100,000 lives annually globally. These benefits are substantial and were achieved with an intervention the cost of which was less than Rs.100/- per patient. For comparison, benefits of far lesser magnitude have been achieved in early breast cancer patients by much more expensive, targeted drugs which cost more than ten lakhs per patient. The clinical trial is hence an important milestone in the treatment of breast cancer.

Facing breast cancer surgery can be overwhelming, but knowledge is power. https://lnkd.in/euB9mGWy This comprehensive guide, based on insights from Dr. Yara Robertson, a renowned breast surgical oncologist and LLL medical advisor, aims to provide you with clear, actionable information about breast cancer surgery options, preparation, and recovery. Whether you’re newly diagnosed or supporting a loved one, understanding the surgical journey can help alleviate anxiety and empower you to make informed decisions. What is the average time between breast cancer diagnosis and surgery? This varies depending on individual circumstances, but it’s typically a few weeks to allow for proper planning and any necessary pre-surgery treatments.

New findings on Pancreatic Undifferentiated Carcinomas with Rhabdoid Features (PUCR)! Despite advances, optimal treatment remains unclear. Our pooled analysis of 28 cases shows surgery doesn't significantly improve survival. Chemotherapy should be the primary treatment approach. Explore the full study for more insights! #CancerResearch #Oncology #PUCR #Chemotherapy Wiktoria Batog Paul Ridgway Tibor Kovacs

CCNW Breast Surgical Oncologist, Dr. Michalina Kupsik, discusses surgical decision making in breast cancer during #BreastCancerAwarenessMonth. A Lumpectomy (aka breast conservation surgery or partial mastectomy) is the removal of the breast tumor and a ring of healthy tissue around the tumor (margin). Patients who undergo a lumpectomy for breast cancer should know: ▶️ A lumpectomy is the least invasive surgical option for breast cancer ▶️ A lumpectomy requires the least amount of anesthesia ▶️ Surgery takes about 1-2 hours to complete ▶️ Recovery time is approximately 2 weeks ▶️ Techniques are used to restore breast aesthetics, including hiding of scars and breast recontouring ▶️ Patients may choose to do more breast-related procedures, which could include a breast lift or breast reduction, performed by a board-certified plastic surgeon ✌🏻Stay tuned for part 2 of this series, where Dr. Kupsik discusses mastectomies. 🛑 Disclaimer – Your oncologist will determine the best treatment option for your breast cancer. Not everyone is a candidate for a lumpectomy. Cancer Care Northwest Specializing in Breast Cancer Treatment 6 clinics in Washington & Idaho (509) 228 - 1000 CancerCareNorthwest.com #breastcancer #breastcancerawareness #lumpectomy #breastconservationsurgery #partialmastectomy #breastcancertreatment #breastcancerysurgery #surgicaloncologist

Prostate cancer patients with lymphatic node involvement detected by immunohistochemistry. Is the effort worthwhile? Introduction: Lymph node (LN) status is one of the main prognostic factors in localized prostate cancer (CaP) patients after surgery. Examining palpable lymph nodes with hematoxylin and eosin (HE) is the most common approach in clinical practice; however, immunohistochemistry (IHC) has been reported to increase the LN detection rate. We reviewed the oncological results of patients with LN metastasis detected by IHC. Extended lymphadenectomy was performed with complementary indocyanine green (ICG) guidance. Three groups were considered according to LN status. Definition of the pN+ group was made if LNs were detected by HE, occulted lymph node-positive (OLN+) was considered when ≥ 1 LN was identified with IHC and occulted lymph node-negative (OLN-) if no metastatic nodes were found. Oncological outcomes were reported regarding PSA kinetics, biochemical recurrence (BCR), need for secondary treatments and metastasis-free survival (MFS). Conclusion: Conventional HE histological analysis underdiagnosed nearly 10% of patients. IHC-detected patients were at higher risk of metastasis development than OLN - patients. This report highlights the importance of optimizing the anatomopathological analysis properly. https://lnkd.in/ea_mc6xT #ICG #indocyaninegreen #fluorescence #fluorescent #guidedsurgery #surgery #surgeon #imaging #thinkgreen #safety #surgical

A groundbreaking innovation leading the charge in improving surgical outcomes for thyroid and parathyroid surgeries is autofluorescence technology. As we stand on the brink of a new era in thyroid and parathyroid surgeries, Moffitt’s Endocrine Oncology Department remains at the forefront of innovation with the use of the autofluorescence evaluation tools and other emerging technologies as part of our endocrine treatments and services. https://lnkd.in/edwTRXAS

Neoadjuvant chemotherapy before breast conserving surgery may not be necessary for T2N0-1M0 HR-positive/HER2-negative BC patients. At The London Breast Institute, we recommend NAC only for specific cases where downsizing for BCS or axillary downstaging to avoid ALND is required, especially for young patients with grade 3 tumors and high Ki67. #BreastCancer #NeoadjuvantChemotherapy #BreastConservingSurgery #LondonBreastInstitute

Reducing Complications in Thyroid Cancer Patients For patients with differentiated thyroid cancer, opting for an initial lobectomy followed by a staged completion thyroidectomy could lower the risk of complications compared to having a total thyroidectomy in one operation. The study, conducted by Tulane's Eman Toraih, MD, PhD, and Emad Kandil, MD, found that patients undergoing the two-stage surgery had reduced rates of hypocalcemia—a condition where calcium levels in the blood are low—in both its transient and permanent forms, compared to those who had a one-stage total thyroidectomy. Furthermore, performing the completion thyroidectomy within 1 to 6 months after the initial lobectomy might further decrease the risk of permanent complications. These findings may help surgeons and patients make more informed decisions about the surgical management of thyroid cancer. By considering a staged surgical approach and carefully timing the second surgery, it might be possible to minimize complications and improve patient outcomes. #TulaneResearch #ThyroidCancer #Medicine #Surgery Read the paper in the comments! Image: Graphical abstract of the study, showing workflow and databases from which patient data was extracted (left), relative risk (RR) for hypocalcemia and other complications in two-stage (blue) versus one-stage (purple) thyroidectomy (middle), and summary conclusion (right).